Industry Research Reports

Home > Reports > Medical Devices & Consumables > Stented Tissue Heart Valve- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Stented Tissue Heart Valve- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Medical Devices & Consumables

Published Date: 2026-01-19

Pages: 93 Pages

Report ld: 5777710

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Stented Tissue Heart Valve Market Size(US$)

CAGR 2026-2032

9.0%

Market Size,2032

USD 682

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 407 million

Market Forecast in 2032(Value)

US$ 682 million

CAGR

9.0%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Stented Tissue Heart Valve was estimated to be worth US$ 376 million in 2025 and is projected to reach US$ 682 million, growing at a CAGR of 9.0% from 2026 to 2032.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Stented Tissue Heart Valve cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Stented Tissue Heart Valves are biologic valves that are made of animal tissue, usually porcine or bovine pericardium or valve tissue, and fixed to a metal or synthetic scaffold and are used to replace diseased heart valves in patients to improve hemodynamic function and reduce the risk of valve-related complications. This valve is designed to provide long-term, stable flow control during heart valve replacement surgery and to mimic the function of a native valve.

The North American market for Stented Tissue Heart Valve was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.

The Asia-Pacific market for Stented Tissue Heart Valve was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.

The European market for Stented Tissue Heart Valve was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.

The global key companies in the Stented Tissue Heart Valve market include Medtronic, Abbott, Edwards Lifesciences, LivaNova, Braile Biomedica, CryoLife, Inc, Meril Life Sciences Pvt. Ltd, etc. In 2025, the five largest players accounted for approximately % of revenue.

This report provides a comprehensive view of the global market for Stented Tissue Heart Valve, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Stented Tissue Heart Valve market size, estimations, and forecasts are presented in terms of sales volume (Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Stented Tissue Heart Valve.

MARKET SEGMENTATION

By Company

Medtronic
Abbott
Edwards Lifesciences
LivaNova
Braile Biomedica
CryoLife, Inc
Meril Life Sciences Pvt. Ltd

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Aortic-valve Replacement
Mitral-valve Replacement

Segment by Application

Hospital
Clinic
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.

Chapter 2: Provides a detailed analysis of the Stented Tissue Heart Valve manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Stented Tissue Heart Valve sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Stented Tissue Heart Valve sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.

Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Stented Tissue Heart Valve Product Introduction

1.2 Global Stented Tissue Heart Valve Market Size Forecast

1.2.1 Global Stented Tissue Heart Valve Sales Value (2021–2032)

1.2.2 Global Stented Tissue Heart Valve Sales Volume (2021–2032)

1.2.3 Global Stented Tissue Heart Valve Sales Price (2021–2032)

1.3 Stented Tissue Heart Valve Market Trends & Drivers

1.3.1 Stented Tissue Heart Valve Industry Trends

1.3.2 Stented Tissue Heart Valve Market Drivers & Opportunities

1.3.3 Stented Tissue Heart Valve Market Challenges

1.3.4 Stented Tissue Heart Valve Market Restraints

1.3.5 Impact of U.S. Tariffs

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Stented Tissue Heart Valve Players Revenue Ranking (2025)

2.2 Global Stented Tissue Heart Valve Revenue by Company (2021–2026)

2.3 Global Stented Tissue Heart Valve Sales Volume Ranking of Players (2025)

2.4 Global Stented Tissue Heart Valve Sales Volume by Company (2021–2026)

2.5 Global Stented Tissue Heart Valve Average Price by Company (2021–2026)

2.6 Key Manufacturers Stented Tissue Heart Valve Manufacturing Base and Headquarters

2.7 Key Manufacturers Stented Tissue Heart Valve Product Offerings

2.8 Key Manufacturers Start of Mass Production of Stented Tissue Heart Valve

2.9 Stented Tissue Heart Valve Market Competitive Analysis

2.9.1 Stented Tissue Heart Valve Market Concentration Rate (2021–2026)

2.9.2 Global 5 and 10 Largest Manufacturers by Stented Tissue Heart Valve Revenue in 2025

2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Stented Tissue Heart Valve revenue, 2025

2.10 Mergers & Acquisitions and Expansion

3 Segmentation Stented Tissue Heart Valve Market Classification

3.1 Introduction by Type

3.1.1 Aortic-valve Replacement

3.1.2 Mitral-valve Replacement

3.1.3 Global Stented Tissue Heart Valve Sales Value by Type

3.1.3.1 Global Stented Tissue Heart Valve Sales Value by Type (2021 vs 2025 vs 2032)

3.1.3.2 Global Stented Tissue Heart Valve Sales Value, by Type (2021–2032)

3.1.3.3 Global Stented Tissue Heart Valve Sales Value, by Type (%), 2021–2032

3.1.4 Global Stented Tissue Heart Valve Sales Volume by Type

3.1.4.1 Global Stented Tissue Heart Valve Sales Volume by Type (2021 vs 2025 vs 2032)

3.1.4.2 Global Stented Tissue Heart Valve Sales Volume, by Type (2021–2032)

3.1.4.3 Global Stented Tissue Heart Valve Sales Volume, by Type (%), 2021–2032

3.1.5 Global Stented Tissue Heart Valve Average Price by Type (2021–2032)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Clinic

4.1.3 Others

4.2 Global Stented Tissue Heart Valve Sales Value by Application

4.2.1 Global Stented Tissue Heart Valve Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Stented Tissue Heart Valve Sales Value, by Application (2021–2032)

4.2.3 Global Stented Tissue Heart Valve Sales Value, by Application (%), 2021–2032

4.3 Global Stented Tissue Heart Valve Sales Volume by Application

4.3.1 Global Stented Tissue Heart Valve Sales Volume by Application (2021 vs 2025 vs 2032)

4.3.2 Global Stented Tissue Heart Valve Sales Volume, by Application (2021–2032)

4.3.3 Global Stented Tissue Heart Valve Sales Volume, by Application (%), 2021–2032

4.4 Global Stented Tissue Heart Valve Average Price by Application (2021–2032)

5 Segmentation by Region

5.1 Global Stented Tissue Heart Valve Sales Value by Region

5.1.1 Global Stented Tissue Heart Valve Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Stented Tissue Heart Valve Sales Value by Region (2021–2026)

5.1.3 Global Stented Tissue Heart Valve Sales Value by Region (2027–2032)

5.1.4 Global Stented Tissue Heart Valve Sales Value by Region (%), 2021–2032

5.2 Global Stented Tissue Heart Valve Sales Volume by Region

5.2.1 Global Stented Tissue Heart Valve Sales Volume by Region: 2021 vs 2025 vs 2032

5.2.2 Global Stented Tissue Heart Valve Sales Volume by Region (2021–2026)

5.2.3 Global Stented Tissue Heart Valve Sales Volume by Region (2027–2032)

5.2.4 Global Stented Tissue Heart Valve Sales Volume by Region (%), 2021–2032

5.3 Global Stented Tissue Heart Valve Average Price by Region (2021–2032)

5.4 North America

5.4.1 North America Stented Tissue Heart Valve Sales Value, 2021–2032

5.4.2 North America Stented Tissue Heart Valve Sales Value by Country (%), 2025 vs 2032

5.5 Europe

5.5.1 Europe Stented Tissue Heart Valve Sales Value, 2021–2032

5.5.2 Europe Stented Tissue Heart Valve Sales Value by Country (%), 2025 vs 2032

5.6 Asia Pacific

5.6.1 Asia Pacific Stented Tissue Heart Valve Sales Value, 2021–2032

5.6.2 Asia Pacific Stented Tissue Heart Valve Sales Value by Region (%), 2025 vs 2032

5.7 South America

5.7.1 South America Stented Tissue Heart Valve Sales Value, 2021–2032

5.7.2 South America Stented Tissue Heart Valve Sales Value by Country (%), 2025 vs 2032

5.8 Middle East & Africa

5.8.1 Middle East & Africa Stented Tissue Heart Valve Sales Value, 2021–2032

5.8.2 Middle East & Africa Stented Tissue Heart Valve Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Stented Tissue Heart Valve Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Stented Tissue Heart Valve Sales Value and Sales Volume

6.2.1 Key Countries/Regions Stented Tissue Heart Valve Sales Value, 2021–2032

6.2.2 Key Countries/Regions Stented Tissue Heart Valve Sales Volume, 2021–2032

6.3 United States

6.3.1 United States Stented Tissue Heart Valve Sales Value, 2021–2032

6.3.2 United States Stented Tissue Heart Valve Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Stented Tissue Heart Valve Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Stented Tissue Heart Valve Sales Value, 2021–2032

6.4.2 Europe Stented Tissue Heart Valve Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Stented Tissue Heart Valve Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Stented Tissue Heart Valve Sales Value, 2021–2032

6.5.2 China Stented Tissue Heart Valve Sales Value by Type (%), 2025 vs 2032

6.5.3 China Stented Tissue Heart Valve Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Stented Tissue Heart Valve Sales Value, 2021–2032

6.6.2 Japan Stented Tissue Heart Valve Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Stented Tissue Heart Valve Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Stented Tissue Heart Valve Sales Value, 2021–2032

6.7.2 South Korea Stented Tissue Heart Valve Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Stented Tissue Heart Valve Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Stented Tissue Heart Valve Sales Value, 2021–2032

6.8.2 Southeast Asia Stented Tissue Heart Valve Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Stented Tissue Heart Valve Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Stented Tissue Heart Valve Sales Value, 2021–2032

6.9.2 India Stented Tissue Heart Valve Sales Value by Type (%), 2025 vs 2032

6.9.3 India Stented Tissue Heart Valve Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Medtronic

7.1.1 Medtronic Company Information

7.1.2 Medtronic Introduction and Business Overview

7.1.3 Medtronic Stented Tissue Heart Valve Sales, Revenue, Price and Gross Margin (2021–2026)

7.1.4 Medtronic Stented Tissue Heart Valve Product Offerings

7.1.5 Medtronic Recent Developments

7.2 Abbott

7.2.1 Abbott Company Information

7.2.2 Abbott Introduction and Business Overview

7.2.3 Abbott Stented Tissue Heart Valve Sales, Revenue, Price and Gross Margin (2021–2026)

7.2.4 Abbott Stented Tissue Heart Valve Product Offerings

7.2.5 Abbott Recent Developments

7.3 Edwards Lifesciences

7.3.1 Edwards Lifesciences Company Information

7.3.2 Edwards Lifesciences Introduction and Business Overview

7.3.3 Edwards Lifesciences Stented Tissue Heart Valve Sales, Revenue, Price and Gross Margin (2021–2026)

7.3.4 Edwards Lifesciences Stented Tissue Heart Valve Product Offerings

7.3.5 Edwards Lifesciences Recent Developments

7.4 LivaNova

7.4.1 LivaNova Company Information

7.4.2 LivaNova Introduction and Business Overview

7.4.3 LivaNova Stented Tissue Heart Valve Sales, Revenue, Price and Gross Margin (2021–2026)

7.4.4 LivaNova Stented Tissue Heart Valve Product Offerings

7.4.5 LivaNova Recent Developments

7.5 Braile Biomedica

7.5.1 Braile Biomedica Company Information

7.5.2 Braile Biomedica Introduction and Business Overview

7.5.3 Braile Biomedica Stented Tissue Heart Valve Sales, Revenue, Price and Gross Margin (2021–2026)

7.5.4 Braile Biomedica Stented Tissue Heart Valve Product Offerings

7.5.5 Braile Biomedica Recent Developments

7.6 CryoLife, Inc

7.6.1 CryoLife, Inc Company Information

7.6.2 CryoLife, Inc Introduction and Business Overview

7.6.3 CryoLife, Inc Stented Tissue Heart Valve Sales, Revenue, Price and Gross Margin (2021–2026)

7.6.4 CryoLife, Inc Stented Tissue Heart Valve Product Offerings

7.6.5 CryoLife, Inc Recent Developments

7.7 Meril Life Sciences Pvt. Ltd

7.7.1 Meril Life Sciences Pvt. Ltd Company Information

7.7.2 Meril Life Sciences Pvt. Ltd Introduction and Business Overview

7.7.3 Meril Life Sciences Pvt. Ltd Stented Tissue Heart Valve Sales, Revenue, Price and Gross Margin (2021–2026)

7.7.4 Meril Life Sciences Pvt. Ltd Stented Tissue Heart Valve Product Offerings

7.7.5 Meril Life Sciences Pvt. Ltd Recent Developments

8 Industry Chain Analysis

8.1 Stented Tissue Heart Valve Industrial Chain

8.2 Stented Tissue Heart Valve Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customer Analysis)

8.5 Sales Model and Sales Channelss

8.5.1 Stented Tissue Heart Valve Sales Model

8.5.2 Sales Channels

8.5.3 Stented Tissue Heart Valve Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Stented Tissue Heart Valve Market Trends

Table 2. Stented Tissue Heart Valve Market Drivers & Opportunities

Table 3. Stented Tissue Heart Valve Market Challenges

Table 4. Stented Tissue Heart Valve Market Restraints

Table 5. Global Stented Tissue Heart Valve Revenue by Company (US$ Million), 2021–2026

Table 6. Global Stented Tissue Heart Valve Revenue Market Share by Company (2021–2026)

Table 7. Global Stented Tissue Heart Valve Sales Volume by Company (Units), 2021–2026

Table 8. Global Stented Tissue Heart Valve Sales Volume Market Share by Company (2021–2026)

Table 9. Global Market Stented Tissue Heart Valve Price by Company (US$/Unit), 2021–2026

Table 10. Key Manufacturers Stented Tissue Heart Valve Manufacturing Base and Headquarters

Table 11. Key Manufacturers Stented Tissue Heart Valve Product Type

Table 12. Key Manufacturers Start of Mass Production of Stented Tissue Heart Valve

Table 13. Global Stented Tissue Heart Valve Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Stented Tissue Heart Valve revenue, 2025

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global Stented Tissue Heart Valve Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global Stented Tissue Heart Valve Sales Value by Type (US$ Million), 2021–2026

Table 18. Global Stented Tissue Heart Valve Sales Value by Type (US$ Million), 2027–2032

Table 19. Global Stented Tissue Heart Valve Sales Market Share in Value by Type (2021–2026)

Table 20. Global Stented Tissue Heart Valve Sales Market Share in Value by Type (2027–2032)

Table 21. Global Stented Tissue Heart Valve Sales Volume by Type: 2021 vs 2025 vs 2032 (Units)

Table 22. Global Stented Tissue Heart Valve Sales Volume by Type (Units), 2021–2026

Table 23. Global Stented Tissue Heart Valve Sales Volume by Type (Units), 2027–2032

Table 24. Global Stented Tissue Heart Valve Sales Market Share in Volume by Type (2021–2026)

Table 25. Global Stented Tissue Heart Valve Sales Market Share in Volume by Type (2027–2032)

Table 26. Global Stented Tissue Heart Valve Price by Type (US$/Unit), 2021–2026

Table 27. Global Stented Tissue Heart Valve Price by Type (US$/Unit), 2027–2032

Table 28. Global Stented Tissue Heart Valve Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. Global Stented Tissue Heart Valve Sales Value by Application (US$ Million), 2021–2026

Table 30. Global Stented Tissue Heart Valve Sales Value by Application (US$ Million), 2027–2032

Table 31. Global Stented Tissue Heart Valve Sales Market Share in Value by Application (2021–2026)

Table 32. Global Stented Tissue Heart Valve Sales Market Share in Value by Application (2027–2032)

Table 33. Global Stented Tissue Heart Valve Sales Volume by Application: 2021 vs 2025 vs 2032 (Units)

Table 34. Global Stented Tissue Heart Valve Sales Volume by Application (Units), 2021–2026

Table 35. Global Stented Tissue Heart Valve Sales Volume by Application (Units), 2027–2032

Table 36. Global Stented Tissue Heart Valve Sales Market Share in Volume by Application (2021–2026)

Table 37. Global Stented Tissue Heart Valve Sales Market Share in Volume by Application (2027–2032)

Table 38. Global Stented Tissue Heart Valve Price by Application (US$/Unit), 2021–2026

Table 39. Global Stented Tissue Heart Valve Price by Application (US$/Unit), 2027–2032

Table 40. Global Stented Tissue Heart Valve Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 41. Global Stented Tissue Heart Valve Sales Value by Region (US$ Million), 2021–2026

Table 42. Global Stented Tissue Heart Valve Sales Value by Region (US$ Million), 2027–2032

Table 43. Global Stented Tissue Heart Valve Sales Value by Region (%), 2021–2026

Table 44. Global Stented Tissue Heart Valve Sales Value by Region (%), 2027–2032

Table 45. Global Stented Tissue Heart Valve Sales Volume by Region (Units): 2021 vs 2025 vs 2032

Table 46. Global Stented Tissue Heart Valve Sales Volume by Region (Units), 2021–2026

Table 47. Global Stented Tissue Heart Valve Sales Volume by Region (Units), 2027–2032

Table 48. Global Stented Tissue Heart Valve Sales Volume by Region (%), 2021–2026

Table 49. Global Stented Tissue Heart Valve Sales Volume by Region (%), 2027–2032

Table 50. Global Stented Tissue Heart Valve Average Price by Region (US$/Unit), 2021–2026

Table 51. Global Stented Tissue Heart Valve Average Price by Region (US$/Unit), 2027–2032

Table 52. Key Countries/Regions Stented Tissue Heart Valve Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 53. Key Countries/Regions Stented Tissue Heart Valve Sales Value, (US$ Million), 2021–2026

Table 54. Key Countries/Regions Stented Tissue Heart Valve Sales Value, (US$ Million), 2027–2032

Table 55. Key Countries/Regions Stented Tissue Heart Valve Sales Volume, (Units), 2021–2026

Table 56. Key Countries/Regions Stented Tissue Heart Valve Sales Volume, (Units), 2027–2032

Table 57. Medtronic Company Information

Table 58. Medtronic Introduction and Business Overview

Table 59. Medtronic Stented Tissue Heart Valve Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 60. Medtronic Stented Tissue Heart Valve Product Offerings

Table 61. Medtronic Recent Developments

Table 62. Abbott Company Information

Table 63. Abbott Introduction and Business Overview

Table 64. Abbott Stented Tissue Heart Valve Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 65. Abbott Stented Tissue Heart Valve Product Offerings

Table 66. Abbott Recent Developments

Table 67. Edwards Lifesciences Company Information

Table 68. Edwards Lifesciences Introduction and Business Overview

Table 69. Edwards Lifesciences Stented Tissue Heart Valve Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 70. Edwards Lifesciences Stented Tissue Heart Valve Product Offerings

Table 71. Edwards Lifesciences Recent Developments

Table 72. LivaNova Company Information

Table 73. LivaNova Introduction and Business Overview

Table 74. LivaNova Stented Tissue Heart Valve Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 75. LivaNova Stented Tissue Heart Valve Product Offerings

Table 76. LivaNova Recent Developments

Table 77. Braile Biomedica Company Information

Table 78. Braile Biomedica Introduction and Business Overview

Table 79. Braile Biomedica Stented Tissue Heart Valve Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 80. Braile Biomedica Stented Tissue Heart Valve Product Offerings

Table 81. Braile Biomedica Recent Developments

Table 82. CryoLife, Inc Company Information

Table 83. CryoLife, Inc Introduction and Business Overview

Table 84. CryoLife, Inc Stented Tissue Heart Valve Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 85. CryoLife, Inc Stented Tissue Heart Valve Product Offerings

Table 86. CryoLife, Inc Recent Developments

Table 87. Meril Life Sciences Pvt. Ltd Company Information

Table 88. Meril Life Sciences Pvt. Ltd Introduction and Business Overview

Table 89. Meril Life Sciences Pvt. Ltd Stented Tissue Heart Valve Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 90. Meril Life Sciences Pvt. Ltd Stented Tissue Heart Valve Product Offerings

Table 91. Meril Life Sciences Pvt. Ltd Recent Developments

Table 92. Key Raw Materials Lists

Table 93. Key Suppliers of Raw Materials Lists

Table 94. Stented Tissue Heart Valve Downstream Customers

Table 95. Stented Tissue Heart Valve Distributors List

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

List of Figures

Figure 1. Stented Tissue Heart Valve Product Picture

Figure 2. Global Stented Tissue Heart Valve Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Stented Tissue Heart Valve Sales Value (US$ Million), 2021–2032

Figure 4. Global Stented Tissue Heart Valve Sales Volume (Units), 2021–2032

Figure 5. Global Stented Tissue Heart Valve Sales Price (US$/Unit), 2021–2032

Figure 6. Stented Tissue Heart Valve Report Years Considered

Figure 7. Global Stented Tissue Heart Valve Players Revenue Ranking (US$ Million), 2025

Figure 8. Global Stented Tissue Heart Valve Sales Volume Ranking of Players (Units), 2025

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Stented Tissue Heart Valve Revenue in 2025

Figure 10. Stented Tissue Heart Valve Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 11. Aortic-valve Replacement Picture

Figure 12. Mitral-valve Replacement Picture

Figure 13. Global Stented Tissue Heart Valve Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Stented Tissue Heart Valve Sales Value Market Share by Type, 2025 & 2032

Figure 15. Global Stented Tissue Heart Valve Sales Volume by Type (Units), 2021 vs 2025 vs 2032

Figure 16. Global Stented Tissue Heart Valve Sales Volume Market Share by Type, 2025 & 2032

Figure 17. Global Stented Tissue Heart Valve Price by Type (US$/Unit), 2021–2032

Figure 18. Product Picture of Hospital

Figure 19. Product Picture of Clinic

Figure 20. Product Picture of Others

Figure 21. Global Stented Tissue Heart Valve Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 22. Global Stented Tissue Heart Valve Sales Value Market Share by Application, 2025 & 2032

Figure 23. Global Stented Tissue Heart Valve Sales Volume by Application (Units), 2021 vs 2025 vs 2032

Figure 24. Global Stented Tissue Heart Valve Sales Volume Market Share by Application, 2025 & 2032

Figure 25. Global Stented Tissue Heart Valve Price by Application (US$/Unit), 2021–2032

Figure 26. North America Stented Tissue Heart Valve Sales Value (US$ Million), 2021–2032

Figure 27. North America Stented Tissue Heart Valve Sales Value by Country (%), 2025 vs 2032

Figure 28. Europe Stented Tissue Heart Valve Sales Value (US$ Million), 2021–2032

Figure 29. Europe Stented Tissue Heart Valve Sales Value by Country (%), 2025 vs 2032

Figure 30. Asia Pacific Stented Tissue Heart Valve Sales Value (US$ Million), 2021–2032

Figure 31. Asia Pacific Stented Tissue Heart Valve Sales Value by Region (%), 2025 vs 2032

Figure 32. South America Stented Tissue Heart Valve Sales Value (US$ Million), 2021–2032

Figure 33. South America Stented Tissue Heart Valve Sales Value by Country (%), 2025 vs 2032

Figure 34. Middle East & Africa Stented Tissue Heart Valve Sales Value (US$ Million), 2021–2032

Figure 35. Middle East & Africa Stented Tissue Heart Valve Sales Value by Country (%), 2025 vs 2032

Figure 36. Key Countries/Regions Stented Tissue Heart Valve Sales Value (%), 2021–2032

Figure 37. Key Countries/Regions Stented Tissue Heart Valve Sales Volume (%), 2021–2032

Figure 38. United States Stented Tissue Heart Valve Sales Value (US$ Million), 2021–2032

Figure 39. United States Stented Tissue Heart Valve Sales Value by Type (%), 2025 vs 2032

Figure 40. United States Stented Tissue Heart Valve Sales Value by Application (%), 2025 vs 2032

Figure 41. Europe Stented Tissue Heart Valve Sales Value (US$ Million), 2021–2032

Figure 42. Europe Stented Tissue Heart Valve Sales Value by Type (%), 2025 vs 2032

Figure 43. Europe Stented Tissue Heart Valve Sales Value by Application (%), 2025 vs 2032

Figure 44. China Stented Tissue Heart Valve Sales Value (US$ Million), 2021–2032

Figure 45. China Stented Tissue Heart Valve Sales Value by Type (%), 2025 vs 2032

Figure 46. China Stented Tissue Heart Valve Sales Value by Application (%), 2025 vs 2032

Figure 47. Japan Stented Tissue Heart Valve Sales Value (US$ Million), 2021–2032

Figure 48. Japan Stented Tissue Heart Valve Sales Value by Type (%), 2025 vs 2032

Figure 49. Japan Stented Tissue Heart Valve Sales Value by Application (%), 2025 vs 2032

Figure 50. South Korea Stented Tissue Heart Valve Sales Value (US$ Million), 2021–2032

Figure 51. South Korea Stented Tissue Heart Valve Sales Value by Type (%), 2025 vs 2032

Figure 52. South Korea Stented Tissue Heart Valve Sales Value by Application (%), 2025 vs 2032

Figure 53. Southeast Asia Stented Tissue Heart Valve Sales Value (US$ Million), 2021–2032

Figure 54. Southeast Asia Stented Tissue Heart Valve Sales Value by Type (%), 2025 vs 2032

Figure 55. Southeast Asia Stented Tissue Heart Valve Sales Value by Application (%), 2025 vs 2032

Figure 56. India Stented Tissue Heart Valve Sales Value (US$ Million), 2021–2032

Figure 57. India Stented Tissue Heart Valve Sales Value by Type (%), 2025 vs 2032

Figure 58. India Stented Tissue Heart Valve Sales Value by Application (%), 2025 vs 2032

Figure 59. Stented Tissue Heart Valve Industrial Chain

Figure 60. Stented Tissue Heart Valve Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Stented Tissue Heart Valve market? zhanKai

The top companies in the global Stented Tissue Heart Valve market are Medtronic、Abbott、Edwards Lifesciences.

What was the global market size of Stented Tissue Heart Valve in 2026? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Stented Tissue Heart Valve in 2032? shouQi

What is the annual compound growth rate of the global Stented Tissue Heart Valve market size from 2026 to 2032? shouQi

Related Reports

Global Stented Tissue Heart Valve Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Stented Tissue Heart Valve market is projected to grow from US$ 376 million in 2025 to US$ 682 million by 2032, at a CAGR of 9.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 136
USD 4900.00
(Single User License)
Global Stented Tissue Heart Valve Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Stented Tissue Heart Valve market size was US$ 376 million in 2025 and is forecast to reach a readjusted size of US$ 682 million by 2032 with a CAGR of 9.0% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 76
USD 4250.00
(Single User License)
Global Stented Tissue Heart Valve Market Research Report 2026
The global Stented Tissue Heart Valve market was valued at US$ 376 million in 2025 and is anticipated to reach US$ 682 million by 2032, at a CAGR of 9.0% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 116
USD 2900.00
(Single User License)
Global Stented Tissue Heart Valve Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Stented Tissue Heart Valve market size was US$ 348 million in 2024 and is forecast to a readjusted size of US$ 631 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 76
USD 4250.00
(Single User License)
Global Stented Tissue Heart Valve Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Stented Tissue Heart Valve market is projected to grow from US$ 348 million in 2024 to US$ 631 million by 2031, at a CAGR of 9.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 139
USD 4900.00
(Single User License)
Stented Tissue Heart Valve - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Stented Tissue Heart Valve was estimated to be worth US$ 348 million in 2024 and is forecast to a readjusted size of US$ 631 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 96
USD 3950.00
(Single User License)
Global Stented Tissue Heart Valve Market Research Report 2025
The global market for Stented Tissue Heart Valve was valued at US$ 348 million in the year 2024 and is projected to reach a revised size of US$ 631 million by 2031, growing at a CAGR of 9.0% during the forecast period.
Published Date: 2025-03-10
Pages: 87
USD 2900.00
(Single User License)
Global and United States Stented Tissue Heart Valve Market Report & Forecast 2024-2030
The global Stented Tissue Heart Valve revenue was US$ 320 million in 2023 and is forecast to a readjusted size of US$ 584 million by 2030 with a CAGR of 9.0% during the review period (2024-2030).
Published Date: 2024-12-26
Pages: 107
USD 4350.00
(Single User License)
Global Stented Tissue Heart Valve Market Insights, Forecast to 2030
Valued at US$ 348 million in 2024, the global Stented Tissue Heart Valve market is forecast to reach US$ 584 million by 2030, at a CAGR of 9.0% during the forecast period.
Published Date: 2024-12-26
Pages: 128
USD 4900.00
(Single User License)
Global Stented Tissue Heart Valve Market Research Report 2024
The global market for Stented Tissue Heart Valve was valued at US$ 320 million in the year 2023 and is projected to reach a revised size of US$ 584 million by 2030, growing at a CAGR of 9.0% during the forecast period.
Published Date: 2024-12-26
Pages: 78
USD 2900.00
(Single User License)

Global Stented Tissue Heart Valve Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Stented Tissue Heart Valve market is projected to grow from US$ 376 million in 2025 to US$ 682 million by 2032, at a CAGR of 9.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 136
USD 4900.00 (Single User License)
Global Stented Tissue Heart Valve Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Stented Tissue Heart Valve market size was US$ 376 million in 2025 and is forecast to reach a readjusted size of US$ 682 million by 2032 with a CAGR of 9.0% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 76
USD 4250.00 (Single User License)
Global Stented Tissue Heart Valve Market Research Report 2026
The global Stented Tissue Heart Valve market was valued at US$ 376 million in 2025 and is anticipated to reach US$ 682 million by 2032, at a CAGR of 9.0% from 2026 to 2032.
Published: 2026-01-08
Pages: 116
USD 2900.00 (Single User License)
Global Stented Tissue Heart Valve Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Stented Tissue Heart Valve market size was US$ 348 million in 2024 and is forecast to a readjusted size of US$ 631 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 76
USD 4250.00 (Single User License)
Global Stented Tissue Heart Valve Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Stented Tissue Heart Valve market is projected to grow from US$ 348 million in 2024 to US$ 631 million by 2031, at a CAGR of 9.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 139
USD 4900.00 (Single User License)
Stented Tissue Heart Valve - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Stented Tissue Heart Valve was estimated to be worth US$ 348 million in 2024 and is forecast to a readjusted size of US$ 631 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 96
USD 3950.00 (Single User License)
Global Stented Tissue Heart Valve Market Research Report 2025
The global market for Stented Tissue Heart Valve was valued at US$ 348 million in the year 2024 and is projected to reach a revised size of US$ 631 million by 2031, growing at a CAGR of 9.0% during the forecast period.
Published: 2025-03-10
Pages: 87
USD 2900.00 (Single User License)
Global and United States Stented Tissue Heart Valve Market Report & Forecast 2024-2030
The global Stented Tissue Heart Valve revenue was US$ 320 million in 2023 and is forecast to a readjusted size of US$ 584 million by 2030 with a CAGR of 9.0% during the review period (2024-2030).
Published: 2024-12-26
Pages: 107
USD 4350.00 (Single User License)
Global Stented Tissue Heart Valve Market Insights, Forecast to 2030
Valued at US$ 348 million in 2024, the global Stented Tissue Heart Valve market is forecast to reach US$ 584 million by 2030, at a CAGR of 9.0% during the forecast period.
Published: 2024-12-26
Pages: 128
USD 4900.00 (Single User License)
Global Stented Tissue Heart Valve Market Research Report 2024
The global market for Stented Tissue Heart Valve was valued at US$ 320 million in the year 2023 and is projected to reach a revised size of US$ 584 million by 2030, growing at a CAGR of 9.0% during the forecast period.
Published: 2024-12-26
Pages: 78
USD 2900.00 (Single User License)